• Aucun résultat trouvé

Особенности непосредственной имплантации при наличии хронических очагов одонтогенной инфекции

N/A
N/A
Protected

Academic year: 2021

Partager "Особенности непосредственной имплантации при наличии хронических очагов одонтогенной инфекции"

Copied!
9
0
0

Texte intégral

(1)

HAL Id: hal-01450892

https://hal.archives-ouvertes.fr/hal-01450892

Submitted on 31 Jan 2017

HAL is a multi-disciplinary open access archive for the deposit and dissemination of scientific re-search documents, whether they are published or not. The documents may come from teaching and research institutions in France or abroad, or from public or pri-vate research centers.

L’archive ouverte pluridisciplinaire HAL, est des-tinée au dépôt et à la diffusion de documents scien-tifiques de niveau recherche, publiés ou non, émanant des établissements d’enseignement et de recherche français ou étrangers, des laboratoires publics ou privés.

Особенности непосредственной имплантации при

наличии хронических очагов одонтогенной инфекции

А.А. Gudaryan, M.G. Drobyazgo, A.N. Shamrai

To cite this version:

(2)

ɄɅȱɇȱɑɇȺ ɆȿȾɂɐɂɇȺ

ɆȿȾɂɑɇȱ ɉȿɊɋɉȿɄɌɂȼɂ



 5HVFDOD%5RVDOHP:-U7HOHV53)LVFKHU5* +DIIDMHH $' 6RFUDQVN\ 66 *XVWDIVVRQ $ )LJXHUHGR &0,PPXQRORJLFDODQGPLFURELRORJLFSURILOHVRIFKURQLF DQG DJJUHVVLYH SHULRGRQWLWLV VXEMHFWV - 3HULRGRQWRO 

 0DQFKLQL * *DUERQDUD $ +HUHPDQV 6 ,P PXQRFKHPLFDO TXDQWLWDWLRQ RI DQWLJHQV E\ VLQJOH UDGLDO LPPXQRGLIIXVLRQ,PPXQRFKHPLVWU\

 0LFKDHO30 ,PPXQRORJLFDO DQG ,QIODPPDWRU\ $VSHFWV RI 3HULRGRQWDO 'LVHDVH &RQWLQXLQJ (GXFDWLRQ &RXUVH

 +XMRHO 3 =LQD / &XQKD&UX] - /RSH] 5 6SHFLILF LQIHFWLRQV DV WKH HWLRORJ\ RI GHVWUXFWLYH SHULRGRQWDO GLVHDVH D V\VWHPDWLF UHYLHZ (XU - 2UDO 6FL  ɋɬɚɬɬɹɧɚɞɿɣɲɥɚɞɨɪɟɞɚɤɰɿʀ      ɍȾɄ Ⱥ.Ⱥ. Ƚɭɞɚɪɶɹɧ, Ɇ.Ƚ. Ⱦɪɨɛɹɡɝɨ, Ⱥ.ɇ. ɒɚɦɪɚɣ









Ɉ

Ɉ

ɋ

ɋ

Ɉ

Ɉ

Ȼ

Ȼ

ȿ

ȿ

ɇ

ɇ

ɇ

ɇ

Ɉ

Ɉ

ɋ

ɋ

Ɍ

Ɍ

ɂ

ɂ





ɇ

ɇ

ȿ

ȿ

ɉ

ɉ

Ɉ

Ɉ

ɋ

ɋ

Ɋ

Ɋ

ȿ

ȿ

Ⱦ

Ⱦ

ɋ

ɋ

Ɍ

Ɍ

ȼ

ȼ

ȿ

ȿ

ɇ

ɇ

ɇ

ɇ

Ɉ

Ɉ

Ƀ

Ƀ





ɂ

ɂ

Ɇ

Ɇ

ɉ

ɉ

Ʌ

Ʌ

Ⱥ

Ⱥ

ɇ

ɇ

Ɍ

Ɍ

Ⱥ

Ⱥ

ɐ

ɐ

ɂ

ɂ

ɂ

ɂ





ɉ

ɉ

Ɋ

Ɋ

ɂ

ɂ





ɇ

ɇ

Ⱥ

Ⱥ

Ʌ

Ʌ

ɂ

ɂ

ɑ

ɑ

ɂ

ɂ

ɂ

ɂ





ɏ

ɏ

Ɋ

Ɋ

Ɉ

Ɉ

ɇ

ɇ

ɂ

ɂ

ɑ

ɑ

ȿ

ȿ

ɋ

ɋ

Ʉ

Ʉ

ɂ

ɂ

ɏ

ɏ





Ɉ

Ɉ

ɑ

ɑ

Ⱥ

Ⱥ

Ƚ

Ƚ

Ɉ

Ɉ

ȼ

ȼ









Ɉ

Ɉ

Ⱦ

Ⱦ

Ɉ

Ɉ

ɇ

ɇ

Ɍ

Ɍ

Ɉ

Ɉ

Ƚ

Ƚ

ȿ

ȿ

ɇ

ɇ

ɇ

ɇ

Ɉ

Ɉ

Ƀ

Ƀ





ɂ

ɂ

ɇ

ɇ

Ɏ

Ɏ

ȿ

ȿ

Ʉ

Ʉ

ɐ

ɐ

ɂ

ɂ

ɂ

ɂ





Ƚɍ «Ⱦɧɟɩɪɨɩɟɬɪɨɜɫɤɚɹ ɦɟɞɢɰɢɧɫɤɚɹ ɚɤɚɞɟɦɢɹ ɆɁ ɍɤɪɚɢɧɵ» ɤɚɮɟɞɪɚ ɯɢɪɭɪɝɢɱɟɫɤɨɣ ɫɬɨɦɚɬɨɥɨɝɢɢ, ɢɦɩɥɚɧɬɨɥɨɝɢɢ ɢ ɩɚɪɨɞɨɧɬɨɥɨɝɢɢ (ɡɚɜ. – ɤ. ɦɟɞ. ɧ. ɇ.Ƚ. ɂɞɚɲɤɢɧɚ) ɭɥ. Ⱦɡɟɪɠɢɧɫɤɨɝɨ, 9, Ⱦɧɟɩɪ, 49044, ɍɤɪɚɢɧɚ

SE «Dnipropetrovsk medical academy of Health Ministry of Ukraine» Oral surgery, implantology and periodontology department

Dzerzhinsky str., 9, Dnipro, 49044, Ukraine e-mail: gudaryan@list.ru

Ʉɥɸɱɟɜɵɟɫɥɨɜɚ ɞɟɧɬɚɥɶɧɚɹ ɢɦɩɥɚɧɬɚɰɢɹ, ɨɞɨɧɬɨɝɟɧɧɚɹ ɢɧɮɟɤɰɢɹ, ɮɨɬɨɞɢɧɚɦɢɱɟɫɤɚɹ ɬɟɪɚɩɢɹ, ɨɫɬɟɨɢɧɬɟɝɪɚɰɢɹ

.H\ZRUGV dental implantation, odontogenic infection, photodynamic therapy, osseointegration  ɊɟɮɟɪɚɬɈɫɨɛɥɢɜɨɫɬɿɛɟɡɩɨɫɟɪɟɞɧɶɨʀɿɦɩɥɚɧɬɚɰɿʀɩɪɢɧɚɹɜɧɨɫɬɿɯɪɨɧɿɱɧɢɯɜɨɝɧɢɳɨɞɨɧɬɨɝɟɧɧɨʀɿɧɮɟɤɰɿʀ Ƚɭɞɚɪ¶ɹɧɈɈȾɪɨɛɹɡɝɨɆȽɒɚɦɪɚɣȺɇ ɍ ɫɬɚɬɬɿ ɩɪɟɞɫɬɚɜɥɟɧɿ ɪɟɡɭɥɶɬɚɬɢ ɡɚɫɬɨɫɭɜɚɧɧɹ ɪɨɡɪɨɛɥɟɧɨɝɨ ɥɿɤɭɜɚɥɶɧɨ-ɩɪɨɮɿɥɚɤɬɢɱɧɨɝɨ ɤɨɦɩɥɟɤɫɭ ɬɚ ɟɮɟɤɬɢɜɧɿɫɬɶ ɛɟɡɩɨɫɟɪɟɞɧɶɨʀ ɿɦɩɥɚɧɬɚɰɿʀ ɜ 66 ɩɚɰɿɽɧɬɿɜ ɿɡ ɯɪɨɧɿɱɧɢɦɢ ɜɨɝɧɢɳɚɦɢ ɨɞɨɧɬɨɝɟɧɧɢɯ ɿɧɮɟɤɰɿɣ ɭ ɩɟɪɢɚɩɿɤɚɥɶɧɿɣ ɞɿɥɹɧɰɿ. Ɇɟɬɚ ɞɨɫɥɿɞɠɟɧɧɹ – ɩɿɞɜɢɳɟɧɧɹ ɩɪɨɮɿɥɚɤɬɢɱɧɢɯ ɡɚɯɨɞɿɜ ɡɚɩɚɥɶɧɨ-ɿɧɮɟɤɰɿɣɧɢɯ ɭɫɤɥɚɞɧɟɧɶ ɿ ɨɩɬɢɦɿɡɚɰɿɹ ɨɫɬɟɨɿɧɬɟɝɪɚɰɿɣɧɢɯ ɩɪɨɰɟɫɿɜ ɩɪɢ ɛɟɡɩɨɫɟɪɟɞɧɿɣ ɿɦɩɥɚɧɬɚɰɿʀ ɩɿɫɥɹ ɜɢɞɚɥɟɧɧɹ ɡɭɛɿɜ, ɡ ɩɟɪɢɚɩɿɤɚɥɶɧɢɦɢ ɜɨɝɧɢɳɚɦɢ ɯɪɨɧɿɱɧɨʀ ɿɧɮɟɤɰɿʀ. ȼɫɬɚɧɨɜɥɟɧɨ, ɳɨ ɡɚɫɬɨɫɭɜɚɧɧɹ ɪɨɡɪɨɛɥɟɧɨɝɨ ɦɟɞɢɱɧɨɝɨ ɤɨɦɩɥɟɤɫɭ ɫɭɩɪɨɜɨɞɭ ɛɟɡɩɨɫɟɪɟɞɧɶɨʀ ɿɦɩɥɚɧɬɚɰɿʀ, ɹɤɢɣ ɜɤɥɸɱɚɽ ɜɢɤɨɪɢɫɬɚɧɧɹ ɦɿɫɰɟɜɨʀ ɮɨɬɨɞɢɧɚɦɿɱɧɨʀ ɬɟɪɚɩɿʀ, ɛɚɝɚɬɨɝɨ ɬɪɨɦɛɨɰɢɬɚɦɢ ɮɿɛɪɢɧɭ ɜ ɹɤɨɫɬɿ ɿɧ'ɽɤɰɿɣ ɿ ɦɟɦɛɪɚɧ, ɞɨɡɜɨɥɢɥɨ ɫɬɜɨɪɢɬɢ ɫɩɪɢɹɬɥɢɜɢɣ ɮɨɧ ɞɥɹ ɡɚɩɨɛɿɝɚɧɧɹ ɪɨɡɜɢɬɤɭ ɡɚɩɚɥɶɧɨ-ɿɧɮɟɤɰɿɣɧɢɯ ɭɫɤɥɚɞɧɟɧɶ ɭ ɩɟɪɢɿɦɩɥɚɧɬɧɿɣ ɡɨɧɿ ɿ ɫɬɜɨɪɢɥɨ ɫɩɪɢɹɬɥɢɜɟ ɬɥɨ ɞɥɹ ɨɫɬɟɨɿɧɬɟɝɪɚɰɿʀ ɿɦɩɥɚɧɬɚɬɿɜ ɭ 97,1% ɞɨɫɥɿɞɠɭɜɚɧɢɯ. 

(3)





16/ Ɍɨɦ XXȱ / 4



optimization of osteo-integrative processes in immediate implantation after tooth extraction, with periapical foci of chronic infection. It was found that the use of the developed medical complex of following up direct implantation includes the use of local photodynamic therapy, platelet, rich in fibrin as a injection and membranes; this allowed to create a favorable background for the prevention of inflammatory and infectious complications in the peri-implant area and created a favorable background for the osseo-integration of implants in 97.1% of the investigated.

(4)
(5)
(6)
(7)
(8)

ɄɅȱɇȱɑɇȺ ɆȿȾɂɐɂɇȺ

ɆȿȾɂɑɇȱ ɉȿɊɋɉȿɄɌɂȼɂ



ɤɨɪɧɟɣ ɡɭɛɨɜ ɫ ɯɪɨɧɢɱɟɫɤɢɦɢ ɨɱɚɝɚɦɢ ɨɞɨɧɬɨ ɝɟɧɧɨɣ ɢɧɮɟɤɰɢɢ ɜ ɩɟɪɢɚɩɢɤɚɥɶɧɨɣ ɨɛɥɚɫɬɢ ɜɤɥɸɱɚɸɳɢɯ ɢɫɩɨɥɶɡɨɜɚɧɢɟ ɦɟɫɬɧɨɣ ɮɨɬɨɞɢɧɚ ɦɢɱɟɫɤɨɣ ɬɟɪɚɩɢɢ ɮɪɚɤɰɢɢ ɬɪɨɦɛɨɰɢɬɚɪɧɨɣ ɦɚɫɫɵ ɛɨɝɚɬɨɣ ɮɢɛɪɢɧɨɦ ɚɭɬɨɤɪɨɜɢ ɜ ɤɚɱɟɫɬɜɟ ɢɧɴɟɤɰɢɣ ɢ ɦɟɦɛɪɚɧ ɩɨɡɜɨɥɢɥɨ ɫɨɡɞɚɬɶ ɛɥɚɝɨ ɩɪɢɹɬɧɵɣ ɮɨɧ ɞɥɹ ɩɪɟɞɨɬɜɪɚɳɟɧɢɹ ɪɚɡɜɢɬɢɹ ɜɨɫɩɚɥɢɬɟɥɶɧɨɢɧɮɟɤɰɢɨɧɧɵɯ ɨɫɥɨɠɧɟɧɢɣ ɜ ɩɟɪɢɢɦɩɥɚɧɬɧɨɣ ɡɨɧɟ ɢ ɫɨɡɞɚɬɶ ɛɥɚɝɨɩɪɢɹɬɧɵɣ ɮɨɧɞɥɹɨɫɬɟɨɢɧɬɟɝɪɚɰɢɢɢɦɩɥɚɧɬɨɜ ȼɕȼɈȾɕ  ɂɫɩɨɥɶɡɨɜɚɧɢɟ ɚɭɬɨɝɟɧɧɨɝɨ ɛɨɝɚɬɨɝɨ ɬɪɨɦ ɛɨɰɢɬɚɦɢɮɢɛɪɢɧɚ L35)ɢD35) ɜɤɨɦɩɥɟɤɫɟɫ ɦɟɫɬɧɨɣ ɧɟɦɟɞɢɤɚɦɟɧɬɨɡɧɨɣ ɚɧɬɢɛɚɤɬɟɪɢɚɥɶɧɨɣ ɮɨɬɨɞɢɧɚɦɢɱɟɫɤɨɣ ɬɟɪɚɩɢɟɣ ɢ ɢɦɦɭɧɨɦɨɞɭɥɹ ɬɨɪɨɦ ©Ɋɨɧɤɨɥɟɣɤɢɧª ɩɪɢ ɧɟɩɨɫɪɟɞɫɬɜɟɧɧɨɣ ɢɦɩɥɚɧɬɚɰɢɢ ɜ ɥɭɧɤɢ ɤɨɪɧɟɣ ɡɭɛɨɜ ɫ ɯɪɨɧɢ ɱɟɫɤɢɦɢ ɨɱɚɝɚɦɢ ɨɞɨɧɬɨɝɟɧɧɨɣ ɢɧɮɟɤɰɢɢ ɜ ɩɟɪɢɚɩɢɤɚɥɶɧɨɣ ɨɛɥɚɫɬɢ ɩɨɡɜɨɥɹɟɬ ɩɨɥɧɨɫɬɶɸ ɥɢɤɜɢɞɢɪɨɜɚɬɶ ɪɚɧɧɢɟ ɜɨɫɩɚɥɢɬɟɥɶɧɵɟ ɨɫɥɨɠ ɧɟɧɢɹɭɢɫɫɥɟɞɭɟɦɵɯ  Ɋɚɡɪɚɛɨɬɚɧɧɵɣ ɤɨɦɩɥɟɤɫ ɫɨɩɪɨɜɨɠɞɟɧɢɹ ɧɟɩɨɫɪɟɞɫɬɜɟɧɧɨɣ ɢɦɩɥɚɧɬɚɰɢɢ ɜ ɥɭɧɤɢ ɤɨɪɧɟɣ ɡɭɛɨɜ ɫ ɯɪɨɧɢɱɟɫɤɢɦɢ ɨɱɚɝɚɦɢ ɨɞɨɧɬɨɝɟɧɧɨɣ ɢɧɮɟɤɰɢɢ ɜ ɩɟɪɢɚɩɢɤɚɥɶɧɨɣ ɨɛɥɚɫɬɢ ɩɨɡɜɨɥɹɟɬ ɞɨɫɬɢɱɶ ɩɨɥɧɨɣ ɪɟɝɟɧɟɪɚɰɢɢ ɤɨɫɬɧɨɣ ɬɤɚɧɢ ɜ  ɫɥɭɱɚɟɜ ɢ ɨɫɬɟɨɢɧɬɟɝɪɚɰɢɢ ɢɦɩɥɚɧɬɚ ɜ ɫɪɨɤɢɧɟɩɪɟɜɵɲɚɸɳɢɟɦɟɫɹɰɚ

ɋ

ɋ

ɉ

ɉ

ɂ

ɂ

ɋ

ɋ

Ɉ

Ɉ

Ʉ

Ʉ





Ʌ

Ʌ

ɂ

ɂ

Ɍ

Ɍ

ȿ

ȿ

Ɋ

Ɋ

Ⱥ

Ⱥ

Ɍ

Ɍ

ɍ

ɍ

Ɋ

Ɋ

ɕ

ɕ





 ȺɪɢɩɨɜɊȺɍɫɨɜɟɪɲɟɧɫɬɜɨɜɚɧɢɟɦɟɬɨɞɨɜɧɟ ɩɨɫɪɟɞɫɬɜɟɧɧɨɣ ɢɦɩɥɚɧɬɚɰɢɢ ɩɪɢ ɭɞɚɥɟɧɢɢ ɧɢɠɧɢɯ ɤɨɪɟɧɧɵɯ ɡɭɛɨɜ ɢ ɢɡɝɨɬɨɜɥɟɧɢɟ ɩɪɨɬɟɡɨɜ ɧɚ ɞɜɭ ɤɨɪɧɟɜɵɯ ɨɩɨɪɧɵɯ ɤɨɧɫɬɪɭɤɰɢɹɯ ɚɜɬɨɪɟɮ ɞɢɫ ɧɚ ɫɨɢɫɤɚɧɢɟ ɭɱɟɧ ɫɬɟɩɟɧɢ ɤɚɧɞ ɦɟɞ ɧɚɭɤ  ɊȺȺɪɢɩɨɜ±Ʉɚɡɚɧɶ±ɫ  ȼɚɫɢɥɶɟɜȺȼ ɉɪɚɤɬɢɱɟɫɤɢɟ ɚɫɩɟɤɬɵ ɤɥɢɧɢ ɱɟɫɤɨɣ ɞɟɧɬɚɥɶɧɨɣ ɢɦɩɥɚɧɬɨɥɨɝɢɢ Ⱥɬɥɚɫ ± ɪɭɤɨ ɜɨɞɫɬɜɨ  Ⱥȼ ȼɚɫɢɥɶɟɜ ɋȻɍɥɢɬɨɜɫɤɢɣ ɇȼȼɚ ɫɢɥɶɟɜ±ɑɟɥɹɛɢɧɫɤ±ɫ  ȾɭɪɧɨɜɨȿȺ Ɉɫɨɛɟɧɧɨɫɬɢ ɩɪɨɜɟɞɟɧɢɹ ɧɟɩɨ ɫɪɟɞɫɬɜɟɧɧɨɣ ɢɦɩɥɚɧɬɚɰɢɢ ɩɨɫɥɟ ɭɞɚɥɟɧɢɹ ɡɭɛɨɜ ɫ ɨɱɚɝɚɦɢ ɯɪɨɧɢɱɟɫɤɨɣ ɨɞɨɧɬɨɝɟɧɧɨɣ ɢɧɮɟɤɰɢɢ  ȿȺȾɭɪɧɨɜɨȺɋɄɥɸɱɚɟɜȺȼɄɨɡɚɤɨɜɋɬɨɦɚɬɨ ɥɨɝ±±ʋ±ɋ  ɄɭɥɚɤɨɜȺȺ ɇɟɩɨɫɪɟɞɫɬɜɟɧɧɚɹ ɢɦɩɥɚɧɬɚɰɢɹ ɢ ɪɨɥɶ ɪɚɧɧɟɣ ɮɭɧɤɰɢɨɧɚɥɶɧɨɣ ɧɚɝɪɭɡɤɢ ɧɚ ɢɦɩɥɚɧɬ ɷɤɫɩɟɪɟɦɟɧɬɚɥɶɧɨɟ ɢɫɫɥɟɞɨɜɚɧɢɟ   ȺȺ Ʉɭɥɚɤɨɜ ȺɀȺɲɭɟɜɋɬɨɦɚɬɨɥɨɝɢɹ±±ʋ±ɋ  ɄɭɥɚɤɨɜȺȺɉɪɨɛɥɟɦɚɢɧɬɟɝɪɚɰɢɢɜɞɟɧɬɚɥɶ ɧɨɣ ɢɦɩɥɚɧɬɨɥɨɝɢɢ  ȺȺ Ʉɭɥɚɤɨɜ Ⱥɋ Ƚɪɢɝɨɪɹɧ  ɋɬɨɦɚɬɨɥɨɝ±±Ɍʋ±ɋ  ɇɟɩɨɫɪɟɞɫɜɟɧɧɚɹ ɢ ɨɬɫɪɨɱɟɧɧɚɹ ɢɦɩɥɚɧɬɚɰɢɹ ɩɪɢ ɪɟɤɨɧɫɬɪɭɤɰɢɢ ɚɥɶɜɟɨɥɹɪɧɨɣ ɱɚɫɬɢ ɧɢɠɧɟɣ ɱɟ ɥɸɫɬɢ  Ɇȼ Ʌɨɦɚɤɢɧ ɋɘɂɜɚɧɨɜ ȺɆɉɚɧɢɧ ȺɇɅɢɬɜɢɧɟɧɤɨ  Ɋɨɫ ɫɬɨɦɚɬɨɥ ɠɭɪɧɚɥ ±  ± ʋ±ɋ  ɊɨɛɭɫɬɨɜɚɌȽ Ɇɟɬɨɞɢɤɚ ɧɟɦɟɞɥɟɧɧɨɣ ɢɦ ɩɥɚɧɬɚɰɢɢ ɩɪɢ ɭɞɚɥɟɧɢɢ ɡɭɛɨɜ  ɌȽɊɨɛɭɫɬɨɜɚ ɂȼɎɟɞɨɪɨɜ  ɉɪɨɛɥɟɦɵ ɫɬɨɦɚɬɨɥɨɝɢɢ ɢ ɧɟɣɪɨɫɬɨ ɦɚɬɨɥɨɝɢɢ±±ʋ±ɋ

 %HFNHU : ,PPHGLDWH LPSODQW SODFHPHQW GLDJ QRVLV WUHDWPHQW SODQQLQJ DQG WUHDWPHQW VWHSV RU VXF FHVVIXO RXWFRPHV  :%HFNHU  - &DOLI 'HQW $VVRF ± ±9RO±Ɋ

 1LFRODV &DSODQDV ([WUDFWLRQ 'HIHFW $VVHVPHQW &ODVVLILFDWLRQ DQG 0DQDJHPHQW  1LFRODV &DSODQDV -DLPH//R]DGD-RVHSK<..DQ,QW-&OLQ,PSODQW 'HQWLVWU\±±9RO1±Ɋ

 5HODWLRQVKLS EHWZHHQ LQGLFDWLRQ IRU WRRWK H[WUDFWLRQ DQG RXWFRPH RI LPPHGLDWH LPSODQWV $UHWUR VSHFWLYH VWXG\ ZLWK  \HDUV RI IROORZXS  %HDWUL] 7D UD]RQD 3DEOR 7DUD]RQD ± $OYDUH] 'DYLG 3DQDUURFKD ± 2OWUDDQG0DULD3HQDUURFKD±'LDJR-&OLQ([S'HQW ±±9RO1±3

 5RVHQTXLVW % ,PPHGLDWH SODFHPHQW RI LPSODQWV LQWRH[WUDFWLRQVRFNHWVLPSODQWVXUYLYDO%5RVHQTXLVW % *UHQWKH  ,QW -2UDO 0D[LOORIDF ,PSODQW ±± 1±Ɋ

 3R]]L $ ,PPHGLDWH ORDGLQJ ZLWK D QRYHO LPSODQW IHDWXUHG E\ YDULDEOHWKUHDGHG JHRPHWU\ LQWHUQDO FRQLFDO FRQQHFWLRQ DQG SODWIRUP VKLIWLQJ WKUHH\HDU UHVXOWV IURP D SURVSHFWLYHFRKRUWVWXGX$3R]]L07DOODULFR3.0R\ (XU-2UDO,PSODQWRO±±9RO1±Ɋ

5

5

(

(

)

)

(

(

5

5

(

(

1

1

&

&

(

(

6

6





 $ULSRY 5$ >,PSURYHPHQW RI PHWKRGV RI GLUHFW

LPSODQWDWLRQ E\ UHPRYLQJ WKH ORZHU PRODU WHHWK DQG SURVWKHWLF ZRUN RQ GYXNRUQHY\K VXSSRUWLQJ VWUXFWXUHV $EVWUDFW 'LV &DQGLGDWH RI PHGLFDO VFLHQFHV@ .D]DQ 5XVVLDQ

 9DVLOLHY$98OLWRYVN\6%9DVLO\HY19>3UDF WLFDO $VSHFWV RI &OLQLFDO 'HQWDO ,PSODQWRORJ\@ $WODV  JXLGH&KHO\DELQVN5XVVLDQ

 'XUQRYR($&OXFKDHY$6&RVDNRY$9>)HDWX UHV RI WKH LPPHGLDWH LPSODQWDWLRQ DIWHU WRRWK H[WUDFWLRQ ZLWK IRFL RI FKURQLF RGRQWRJHQLF LQIHFWLRQ@ 6WRPDWRORJ 5XVVLDQ

 .XODNRY $$ $VKXHYD $ >,PPHGLDWH LPSODQ WDWLRQDQGWKHUROHRIHDUO\IXQFWLRQDOORDGRQWKHLPSODQW H[SHULPHQWDO UHVHDUFK @ 6WRPDWRORJL\D  5XVVLDQ

 .XODNRY $$ *ULJRU\DQ $6 >7KH SUREOHP RI LQWHJUDWLRQ LQ GHQWDO LPSODQWRORJ\@ 6WRPDWRORJ   5XVVLDQ

(9)





16/ Ɍɨɦ XXȱ / 4



 5REXVWRYD 7* )HGRURY ,9 >0HWKRG RI LPPH GLDWH LPSODQWDWLRQ RI WKH UHPRYDO RI WHHWK@ 3UREOHP\ VWRPDWRORJLLLQH\URVWRPDWRORJLL5XVVLDQ

 %HFNHU:,PPHGLDWHLPSODQWSODFHPHQWGLDJQR VLV WUHDWPHQW SODQQLQJ DQG WUHDWPHQW VWHSV RU VXFFHVVIXO RXWFRPHV-&DOLI'HQW$VVRF

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ɋɬɚɬɬɹɧɚɞɿɣɲɥɚɞɨɪɟɞɚɤɰɿʀ     ɍȾɄ ɂ.ɋ. Ɇɚɳɟɧɤɨ, ȼ.ɂ. ɋɬɪɭɤ *, ɇ.ȼ. ȼɚɬɚɦɚɧɸɤ *









   

Ɇ

Ɇ

ɂ

ɂ

Ʉ

Ʉ

Ɋ

Ɋ

Ɉ

Ɉ

Ȼ

Ȼ

ɂ

ɂ

Ɉ

Ɉ

Ʌ

Ʌ

Ɉ

Ɉ

Ƚ

Ƚ

ɂ

ɂ

ɑ

ɑ

ȿ

ȿ

ɋ

ɋ

Ʉ

Ʉ

ɂ

ɂ

ȿ

ȿ









ɂ

ɂ





ɂ

ɂ

Ɇ

Ɇ

Ɇ

Ɇ

ɍ

ɍ

ɇ

ɇ

Ɉ

Ɉ

Ʌ

Ʌ

Ɉ

Ɉ

Ƚ

Ƚ

ɂ

ɂ

ɑ

ɑ

ȿ

ȿ

ɋ

ɋ

Ʉ

Ʉ

ɂ

ɂ

ȿ

ȿ









Ʉ

Ʉ

Ɋ

Ɋ

ɂ

ɂ

Ɍ

Ɍ

ȿ

ȿ

Ɋ

Ɋ

ɂ

ɂ

ɂ

ɂ





Ⱦ

Ⱦ

ɂ

ɂ

Ⱥ

Ⱥ

Ƚ

Ƚ

ɇ

ɇ

Ɉ

Ɉ

ɋ

ɋ

Ɍ

Ɍ

ɂ

ɂ

Ʉ

Ʉ

ɂ

ɂ





ɇ

ɇ

Ⱥ

Ⱥ

ɑ

ɑ

Ⱥ

Ⱥ

Ʌ

Ʌ

ɖ

ɖ

ɇ

ɇ

Ɉ

Ɉ

Ƀ

Ƀ





ɋ

ɋ

Ɍ

Ɍ

ȿ

ȿ

ɉ

ɉ

ȿ

ȿ

ɇ

ɇ

ɂ

ɂ





Ƚ

Ƚ

ȿ

ȿ

ɇ

ɇ

ȿ

ȿ

Ɋ

Ɋ

Ⱥ

Ⱥ

Ʌ

Ʌ

ɂ

ɂ

Ɂ

Ɂ

Ɉ

Ɉ

ȼ

ȼ

Ⱥ

Ⱥ

ɇ

ɇ

ɇ

ɇ

Ɉ

Ɉ

Ƚ

Ƚ

Ɉ

Ɉ





ɉ

ɉ

Ⱥ

Ⱥ

Ɋ

Ɋ

Ɉ

Ɉ

Ⱦ

Ⱦ

Ɉ

Ɉ

ɇ

ɇ

Ɍ

Ɍ

ɂ

ɂ

Ɍ

Ɍ

Ⱥ

Ⱥ





ɇ

ɇ

Ⱥ

Ⱥ





ɋ

ɋ

Ɍ

Ɍ

Ⱥ

Ⱥ

Ⱦ

Ⱦ

ɂ

ɂ

ɂ

ɂ





Ⱦ

Ⱦ

Ɉ

Ɉ

Ɋ

Ɋ

ȿ

ȿ

ɇ

ɇ

Ɍ

Ɍ

Ƚ

Ƚ

ȿ

ȿ

ɇ

ɇ

Ɉ

Ɉ

Ʌ

Ʌ

Ɉ

Ɉ

Ƚ

Ƚ

ɂ

ɂ

ɑ

ɑ

ȿ

ȿ

ɋ

ɋ

Ʉ

Ʉ

Ɉ

Ɉ

Ƚ

Ƚ

Ɉ

Ɉ





ɉ

ɉ

Ɋ

Ɋ

Ɉ

Ɉ

ə

ə

ȼ

ȼ

Ʌ

Ʌ

ȿ

ȿ

ɇ

ɇ

ɂ

ɂ

ə

ə





Ƚɍ «Ⱦɧɟɩɪɨɩɟɬɪɨɜɫɤɚɹ ɦɟɞɢɰɢɧɫɤɚɹ ɚɤɚɞɟɦɢɹ ɆɁ ɍɤɪɚɢɧɵ» ɤɚɮɟɞɪɚ ɯɢɪɭɪɝɢɱɟɫɤɨɣ ɫɬɨɦɚɬɨɥɨɝɢɢ, ɢɦɩɥɚɧɬɨɥɨɝɢɢ ɢ ɩɚɪɨɞɨɧɬɨɥɨɝɢɢ (ɡɚɜ. – ɤ. ɦɟɞ. ɧ. ɇ.Ƚ. ɂɞɚɲɤɢɧɚ) ɭɥ. Ⱦɡɟɪɠɢɧɫɤɨɝɨ, 9, Ⱦɧɟɩɪ, 49044, ɍɤɪɚɢɧɚ Ƚɍ «Ȼɭɤɨɜɢɧɫɤɢɣ ɝɨɫɭɞɚɪɫɬɜɟɧɧɵɣ ɦɟɞɢɰɢɧɫɤɢɣ ɭɧɢɜɟɪɫɢɬɟɬ» * ɤɚɮɟɞɪɚ ɨɪɬɨɩɟɞɢɱɟɫɤɨɣ ɫɬɨɦɚɬɨɥɨɝɢɢ (ɡɚɜ. – ɤ. ɦɟɞ. ɧ. ɇ.Ȼ. Ʉɭɡɧɹɤ) Ɍɟɚɬɪɚɥɶɧɚɹ ɩɥ., 2, ɑɟɪɧɨɜɰɵ, 58002, ɍɤɪɚɢɧɚ

SE «Dnipropetrovsk medical academy of Health Ministry of Ukraine» Oral surgery, implantology and periodontology department

Dzerzhinsky str., 9, Dnipro, 49044, Ukraine e-mail: gudaryan@list.ru

SE «Bukovinian state medical university» *

Department of prosthetic dentistry

Theatralna sq., 2, Chernivtsi, 58002, Ukraine e-mail: office@bsmu.edu.ua

Ʉɥɸɱɟɜɵɟɫɥɨɜɚ ɝɟɧɟɪɚɥɢɡɨɜɚɧɧɵɣ ɩɚɪɨɞɨɧɬɢɬ, ɦɢɤɪɨɛɢɨɰɟɧɨɡ, ɢɦɦɭɧɨɞɟɮɢɰɢɬ .H\ZRUGV generalized periodontitis, microbiocenosis, immunodeficiency



Références

Documents relatifs

В статье рассмотрены особенности использования модельно-управляемого подхода при разработке агентных имитационных моделей, приведен обзор

либо 50 мг гидрокортизона внутривенно каждые 8 часов) на протяжении 7–10 дней у пациентов с тяжелым и крайне тяжелым течением COVID-19, а также

В дополнение к регулярному тестированию в медицинских учреждениях для ключевых групп населения во всех условиях следует предлагать тестирование на ВИЧ

Ɇɧɨɝɢɦɢ ɟɜɪɨɩɟɣɫɤɢɦɢ ɝɨɫɭɞɚɪɫɬɜɚɦɢ - ɱɥɟɧɚɦɢ ȼɈɁ ɪɚɡɪɚɛɨɬɚɧɚ ɧɚɰɢɨɧɚɥɶɧɚɹ ɩɨɥɢɬɢɤɚ ɜ ɨɛɥɚɫɬɢ ɩɢɳɟɜɵɯ ɩɪɨɞɭɤɬɨɜ ɢ ɩɢɬɚɧɢɹ, ɯɨɬɹ, ɤɨɝɞɚ ɝɨɫɭɞɚɪɫɬɜɚ ɫɞɚɜɚɥɢ

ɇɟɫɦɨɬɪɹ ɧɚ ɬɨ ɱɬɨ ɬɵɫɹɱɢ ɬɨɤɫɢɱɧɵɯ ɯɢɦɢɤɚɬɨɜ ɢ ɩɚɬɨɝɟɧɧɵɯ ɦɢɤɪɨɨɪɝɚɧɢɡɦɨɜ ɛɵɥɢ ɢɫɫɥɟɞɨɜɚɧɵ ɜ ɪɚɤɭɪɫɟ ɢɯ ɩɪɢɝɨɞɧɨɫɬɢ ɜ ɤɚɱɟɫɬɜɟ ɨɪɭɠɢɹ

В настоящее время два вопроса вызывают особое беспокойство в связи с проблемами для здоровья по методологии МОС/ФТК: первый состоит в том,

Беременным женщинам с подозрением на инфицирование 2019-nCoV или при наличии подтвержденной инфекции необходимо назначать поддерживающую терапию,

Беременным женщинам с подозрением на инфицирование nCoV или при наличии подтвержденной инфекции необходимо назначать поддерживающую терапию, описанную